Mallinckrodt $2.3 billion acquisition of Ikaria

Overview:

• Mallinckrodt has completed its $2.3 billion acquisition of fellow pharmaceutical company Ikaria.
• Malinckrodt is headquartered in Ireland and listed on the NYSE.
• Ikaria was sold by private equity firm Madison Dearborn Partners, who had purchased Ikaria in 2013.
• Wachtell Lipton Rosen & Katz advised Mallinckrodt.
• Arthur Cox (Stephen Ranalow) provided Irish counsel for Mallinckrodt.
• Kirkland & Ellis (Sanford Perl, Mark Fennell, Matthew Mauney) advised Ikaria and Madison Dearborn.

Kurt Stumpo - Journalist - North America and the Caribbean